Diana Roettger, PhD, and Olga Kubassova, PhD[email protected]MRIAdvanced imaging offers insight into targeted therapiesMajor breakthroughs are emerging in the development of targeted therapies that use the body's own immune system to attack cancer cells. But traditional methods of measuring the success of drug candidates are slow and expensive. Could advanced imaging help? Diana Roettger, PhD, and Olga Kubassova, PhD, of the Image Analysis Group offer a perspective.February 5, 2019Page 1 of 1Top StoriesMolecular ImagingSNMMI: New molecular imaging agent shows promise for detecting HCCA new molecular imaging agent has shown high sensitivity and specificity in detecting hepatocellular carcinoma (HCC).Molecular ImagingSNMMI: PET imaging improves OMD detection in breast cancer patientsMolecular ImagingSNMMI: F-18 FDS PET distinguishes molds in invasive fungal infectionsMolecular ImagingSNMMI: New immuno-PET tracer awarded Image of the YearSponsor ContentJoin Us June 26 at 12 Noon ET for a FREE webinar!
